id: methadone_access_in_otp_to_drug_court_completion
name: Access to Methadone in Opioid Treatment Programs â†’ Drug Treatment Court Program
  Completion
from_node:
  node_id: methadone_access_in_otp
  node_name: Access to Methadone in Opioid Treatment Programs
to_node:
  node_id: drug_court_completion
  node_name: Drug Treatment Court Program Completion
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Methadone provided through Opioid Treatment Programs (OTPs) offers daily
  supervised dosing and comprehensive support services'
- 'Step 2: The structure of OTP programs provides consistent engagement with treatment
  providers and accountability mechanisms'
- 'Step 3: Methadone''s pharmacological properties provide effective opioid receptor
  agonist therapy, reducing withdrawal and cravings more effectively for some individuals'
- 'Step 4: Enhanced treatment engagement and symptom management support participants
  in meeting drug court requirements and completing the program'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'M. Fendrich and Thomas P. Lebel 2019. "Implementing access to
    medication assisted treatment in a drug treatment court: Correlates, consequences,
    and obstacles." *Journal of Offender Rehabilitation*. https://doi.org/10.1080/10509674.2019.1582573'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.662049'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: medication_type
  direction: strengthens
  strength: moderate
  description: Methadone specifically showed trends toward better completion rates
    compared to other MAT types (injectable naltrexone was most common but showed
    no association with completion)
